Thyrocare, a leading diagnostic and preventive healthcare service provider in India, has entered into a Business Transfer Agreement with Polo Labs Private Limited to acquire their pathology diagnostic business. This strategic acquisition expands Thyrocare’s Footprints into the Northern part of India, further solidifying its position as a dominant player in the Indian diagnostic industry.
Calgary-based pre-clinical stage pharmaceutical development biotechnology company Marvel Biosciences Corporation and its wholly owned subsidiary Marvel Biotechnology Inc, have announced the extension of its collaboration with Drs. Julie Le Merrer and Jerome Becker, lead investigators at the iBraiN Institute in Tours France. Building upon the promising results using MB204 in an autism model earlier this year, we now aim to test our lead asset in a mouse model of Rett syndrome.
The Department of Pharmaceuticals (DoP) is targeting the production of pharmaceuticals under the production linked incentive (PLI) scheme for pharmaceuticals at Rs. 90,000 crore during the fiscal year 2024-25. The investment committed for the scheme during fiscal year is around Rs. 5,000 crore.
The Committee on Immunization of Quebec (Comité sur l’immunisation du Québec - CIQ) has recommended use of RSV (respiratory syncytial virus) vaccines, including Arexvy, for the prevention of RSV among older adults at increased risk of severe outcomes from the virus. Specifically, CIQ recommends vaccination for older adults living in residential and long-term care centres (CHSLDs), intermediate resources (RI-SAPA), as well as adults aged 75 and older living in private seniors’ residences and those with chronic illnesses living in the community.
Cupid Limited, a leading name in the contraceptive and personal wellness industry, proudly announces its enhanced e-commerce presence on India's premier online marketplaces, including Amazon.in, Flipkart, and 1mg.
Glenmark Life Sciences Ltd has reported Standalone financial results for the period ended June 30, 2024.nnGlenmark Life Sciences has posted net profit of Rs. 111.483 crores for the period ended June 30, 2024 as against net profit of Rs. 97.937 crores for the period ended March 31, 2024. The company posted net profit of Rs.135.450 crores for the period ended June 30, 2023.
Emcure Pharmaceuticals Ltd., one of the leading Indian pharmaceutical company with a differentiated product portfolio, together with its subsidiary Gennova Biopharmaceuticals Limited announces the signing of a 22.78 MWp DC Solar Power Purchase Agreement (PPA) with Sunsure Energy, one of India's leading renewable power producers.
The 14-year-old boy from Malappuram, Kerala, who was undergoing treatment for Nipah infection, passed away on Sunday, according to state Health Minister Veena George. George reported that the boy from Pandikkad suffered a massive cardiac arrest at 10:50 am, and efforts to revive him were unsuccessful. The Minister also mentioned that there are 246 people on the boy's contact list, with 63 identified as high-risk. Amid rising concerns about the virus spread, the causes, symptoms, and treatment of Nipah virus are listed below:
India's rapid urbanisation and economic growth have led to a spike in chronic diseases, including diabetes, particularly in rural areas. Increased disposable income, sedentary lifestyles, and unhealthy eating habits are driving this trend. Addressing these health challenges requires a consistent approach prioritising early detection, balanced diets, and education on diabetes management. nnRead more at: nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/diabetes-management-in-the-time-of-urbanisation-an-indian-perspective/articleshow/112015823.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
Health insurance is not very popular in India due to conflict of interests. There is a trust deficit between hospitals, patients and insurance companies. Insurance data says not even 5% of the insured are diabetic? That is impossible because insurance companies rely on people’s declaration. nnnRead more at: nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/govt-funded-healthcare-cant-work-in-countries-with-large-populations-narayana-health-founder-dr-shetty/articleshow/112022647.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst